Boston Scientific (BSX) Long-Term Debt Repayments (2009 - 2020)

Boston Scientific has disclosed Long-Term Debt Repayments across 11 years of filings, most recently posting $1.4 billion for Q2 2020.

• Long-Term Debt Repayments for Q2 2020 came in at $1.4 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $1.4 billion (up 200.63% YoY), and the FY2020 annual result was $1.9 billion, changed N/A from the prior year.
• Long-Term Debt Repayments came in at $1.4 billion for Q2 2020 at Boston Scientific, up from $479.0 million in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $1.6 billion in Q3 2017 to a low of -$1.2 billion in Q4 2017.
• The 4-year median for Long-Term Debt Repayments is $335.0 million (2016), against an average of $405.8 million.
• Across the five-year window, Long-Term Debt Repayments tumbled 480.0% in 2017 and surged 140.8% in 2018, its largest moves.
• Boston Scientific's Long-Term Debt Repayments stood at $320.0 million in 2016, then sank by 480.0% to -$1.2 billion in 2017, then soared by 97.29% to -$33.0 million in 2018, then surged by 4463.64% to $1.4 billion in 2020.
• The last three Long-Term Debt Repayments figures came in at $1.4 billion (Q2 2020), $479.0 million (Q1 2020), and -$33.0 million (Q2 2018), per Business Quant data.